This workshop aims to bring together experts from Europe and Africa to explore potential use and applications of pharmacoeconomic tools for medicines, medical devices, and diagnostics.
Session
Trends and methods in health economics
Date: Sunday, 31 October 2021
Time: 9:00
| Pharmacoeconomic modelling Johanna Lister, Takeda, Global Pricing and Access, Global Health Economics Lead, Zuerich, Switzerland |
| Total-cost-of-care models Praneet Valodia, University of the Western Cape and Praneet Valodia Consulting, Cape Town, South Africa |
| Provision of oncological care in selected African countries Christine Holmberg, Head, Institute for Social Medicine and Epidemiology, Fontane Medical School, Brandenburg, Germany |
| Advancing cancer care in Africa via public-private-partnerships – the perspective of the biopharmaceutical industry Ruth Field, AstraZeneca, Director Market Access Oncology, Respiratory, Cardiometabolic, Diabetes & General Medicine, Bryanston, South Africa |
| Using cost models and pharmacoeconomics in supporting COVID-19 decision making Jacqui Miot, Division Director, Health Economics & Epidemiology Research Office, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa |
| Pharmacoeconomics in neglected tropical diseases: the case of mycetoma Ed Zijlstra, Expert in PKDL/Mycetoma, DNDi, Geneva, Switzerland |
| Establishment of SARS-CoV-2 diagnostic facilities in Africa – Example of German-Africa cooperation Tom Halgasch, Das Labor Potsdam, Germany |
